Effect of Buteyko Breathing Retraining on Respiratory Indices, activity and anxiety level, in Patients with Anxiety Disorder - A Randomized controlled Trial

Phase 3

Completed

• Conditions: Patients with General Anxiety disorder.; Generalized anxiety disorder; F41.1

• Registration Number: IRCT20181017041374N1
• Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 24 February 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Patients with anxiety disorder diagnosed by a physician
Not having any illness or musculoskeletal-musculoskeletal system interfering with breathing and based on the examination and evaluation that the investigator will examine.
Not having addiction to any drugs or cigarettes and alcohol
Have a high school diploma degree
The company does not have to do any physical or sporting activities professionally and earn points from the Beck Action Level Questionnaire.
No breathing exercises have been performed, such as Buteyko exercises or other exercises
Individuals with respiratory pattern of hyperventilation, who were evaluated by a semiann questionnaire score 23 to 64 to enter the study.

Exclusion Criteria

In case of unwillingness and tolerance of treatment intervention
Pulse of heart over normal range based on age
The presence of any problems with the upper airways, including polyps, and the deviation of the nasal blades that lead to breathing through the mouth and preventing breathing. This criterion is made through the rapid and common tests in the auditory services of the ENT and by the research team.
Any dizziness and headache or nausea during or after exercise
Excessive concern during the implementation of the project in such a way that the process of conducting research is compromised
Cardiovascular disease based on self-expression
Mentally retarded patients
Pregnant

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
GAD-7 and Beck Anxiety Q?uestionnaire Scores. Timepoint: At the beginning of the intervention, during the study, approximately 4 weeks later, and at the end of the study, 8 weeks later. Method of measurement: Beck and GAD-7 Anxiety Inventory and Nigmegen Respiratory Function Questionnaire.